August 2023 FDA Recall Sucralfate by Vistapharm Llc
D-1149-2023 - Superpotent/Subpotent single ingredient Drug

This Class II drug recall was voluntarily initiated by Vistapharm Llc on August 30, 2023 for the product Sucralfate. The FDA reported the reason for recall as superpotent/subpotent single ingredient drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1149-2023

Reason for Recall
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
Initiated
08-30-2023
Reported
09-20-2023
Quantity
14,400 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Distributed nationwide to 68 consignees in the U.S.
Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16

Batch or Lot Expiration Information

Lot# : 921100; Exp. 02/2025

Affected Packages Involved in this Recall